Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

The use of the RESPeRATE device to lower blood pressure in inner city obese adolescents and children: a pilot feasibility study.

Wojcicki JM, Geissler JD, Stokes CW, Heyman MB, Tran CT.

High Blood Press Cardiovasc Prev. 2013 Jun;20(2):89-92. doi: 10.1007/s40292-013-0014-3. Epub 2013 May 8.

2.

Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trial.

Landman GW, Drion I, van Hateren KJ, van Dijk PR, Logtenberg SJ, Lambert J, Groenier KH, Bilo HJ, Kleefstra N.

JAMA Intern Med. 2013 Jul 22;173(14):1346-50. doi: 10.1001/jamainternmed.2013.6883.

PMID:
23752780
3.

RESPeRATE: the role of paced breathing in hypertension treatment.

Cernes R, Zimlichman R.

J Am Soc Hypertens. 2015 Jan;9(1):38-47. doi: 10.1016/j.jash.2014.10.002. Epub 2014 Oct 16. Review.

PMID:
25539897
4.

Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial.

Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Bilo HJ.

J Hypertens. 2007 Jan;25(1):241-6.

PMID:
17143197
5.

Treating hypertension with a device that slows and regularises breathing: a randomised, double-blind controlled study.

Schein MH, Gavish B, Herz M, Rosner-Kahana D, Naveh P, Knishkowy B, Zlotnikov E, Ben-Zvi N, Melmed RN.

J Hum Hypertens. 2001 Apr;15(4):271-8.

6.

What constitutes an adequate evaluation of device-guided breathing?

Huang AJ, Subak LL.

JAMA Intern Med. 2014 Apr;174(4):637. doi: 10.1001/jamainternmed.2013.13791. No abstract available.

PMID:
24711181
7.

What constitutes an adequate evaluation of device-guided breathing?-Reply.

Landman GW, van Hateren KJ, Kleefstra N.

JAMA Intern Med. 2014 Apr;174(4):638. doi: 10.1001/jamainternmed.2013.13790. No abstract available.

PMID:
24711183
8.

Effect of device-guided breathing exercises on blood pressure in patients with hypertension: a randomized controlled trial.

Altena MR, Kleefstra N, Logtenberg SJ, Groenier KH, Houweling ST, Bilo HJ.

Blood Press. 2009;18(5):273-9. doi: 10.3109/08037050903272925.

PMID:
19919399
9.

Reduction of sympathetic nervous activity with device-guided breathing.

de Barros S, da Silva GV, de Gusmão JL, de Araujo TG, Mion D Jr.

J Clin Hypertens (Greenwich). 2014 Aug;16(8):614-5. doi: 10.1111/jch.12360. Epub 2014 Jun 23. No abstract available.

10.

RESPeRATE: nonpharmacological treatment of hypertension.

Sharma M, Frishman WH, Gandhi K.

Cardiol Rev. 2011 Mar-Apr;19(2):47-51. doi: 10.1097/CRD.0b013e3181fc1ae6. Review.

PMID:
21285661
11.
12.

Pharmacist-led screening program for an inner-city pediatric population.

Elliott JP, Harrison C, Konopka C, Wood J, Marcotullio N, Lunney P, Skoner D, Gentile D.

J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):413-8. doi: 10.1331/JAPhA.2015.14273.

PMID:
26117001
13.

Psychological predictors of the antihypertensive effects of music-guided slow breathing.

Modesti PA, Ferrari A, Bazzini C, Costanzo G, Simonetti I, Taddei S, Biggeri A, Parati G, Gensini GF, Sirigatti S.

J Hypertens. 2010 May;28(5):1097-103. doi: 10.1097/HJH.0b013e3283362762.

PMID:
20160655
14.

Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial.

Schein MH, Gavish B, Baevsky T, Kaufman M, Levine S, Nessing A, Alter A.

J Hum Hypertens. 2009 May;23(5):325-31. doi: 10.1038/jhh.2008.135. Epub 2008 Nov 13.

PMID:
19005477
15.

Effects of guided breathing on blood pressure and heart rate variability in hypertensive diabetic patients.

Howorka K, Pumprla J, Tamm J, Schabmann A, Klomfar S, Kostineak E, Howorka N, Sovova E.

Auton Neurosci. 2013 Dec;179(1-2):131-7. doi: 10.1016/j.autneu.2013.08.065. Epub 2013 Aug 27.

PMID:
24021938
16.

Device-guided breathing exercises in the control of human blood pressure: systematic review and meta-analysis.

Mahtani KR, Nunan D, Heneghan CJ.

J Hypertens. 2012 May;30(5):852-60. doi: 10.1097/HJH.0b013e3283520077. Review.

PMID:
22495126
17.

Design and rationale for NOURISH-T: a randomized control trial targeting parents of overweight children off cancer treatment.

Stern M, Ewing L, Davila E, Thompson AL, Hale G, Mazzeo S.

Contemp Clin Trials. 2015 Mar;41:227-37. doi: 10.1016/j.cct.2014.12.018. Epub 2015 Jan 2.

PMID:
25559916
18.

Sympathetic nerve activity is decreased during device-guided slow breathing.

Oneda B, Ortega KC, Gusmão JL, Araújo TG, Mion D Jr.

Hypertens Res. 2010 Jul;33(7):708-12. doi: 10.1038/hr.2010.74. Epub 2010 Jun 3.

PMID:
20520613
19.

Gender and obesity modify the impact of salt intake on blood pressure in children.

Correia-Costa L, Cosme D, Nogueira-Silva L, Morato M, Sousa T, Moura C, Mota C, Guerra A, Albino-Teixeira A, Areias JC, Schaefer F, Lopes C, Afonso AC, Azevedo A.

Pediatr Nephrol. 2016 Feb;31(2):279-88. doi: 10.1007/s00467-015-3210-7. Epub 2015 Sep 29.

PMID:
26420679
20.

Device-Guided Breathing for Hypertension: a Summary Evidence Review.

Mahtani KR, Beinortas T, Bauza K, Nunan D.

Curr Hypertens Rep. 2016 Apr;18(4):33. doi: 10.1007/s11906-016-0631-z. Review.

PMID:
27059041

Supplemental Content

Support Center